Vet Peptide Suppliers site na mbipụta akwụkwọ: Ntuziaka ọnụọgụgụ

Ọnyà mbipụta akwụkwọ: Ihe kpatara aha ọnụọgụ abụọ ji gụta nyocha nzụta ọdịda ọdịda

Ịtụle ndị na-enye peptide omenala naanị site na mkpokọta ngụkọ na-emepụta ntụkwasị obi ụgha. Na akwụkwọ agụmakwụkwọ na ụlọ ọrụ mmepụta ihe, Ntụle reagent dị iche iche na nghọta, teknụzụ omimi, na nkwenye ọkwa ọkwa.

Dị ka ọmụmaatụ, akwụkwọ na-ekwu "E nwetara Peptides n'aka Vendor X" na-enye ihe fọrọ nke nta ka ọ bụrụ enweghị nghọta nwere ike ime maka otu mmepe usoro biopharma. Ọ na-ahapụ ajụjụ arụ ọrụ dị oke mkpa na-azaghị:

• Ọ bụ ahaziri peptide ka ọ tụọ, ma ọ bụ nyere iwu site na ngụkọ katalọgụ ahaziburu?

• Ndi odee gosiputara njirimara usoro, ịdị ọcha, na nchikota nnu n'ime ụlọ nyocha nke ha, ma ọ bụ na ha nabatara nkọwa ndị na-ere ahịa na ọnụ ahịa ihu?

• Peptide Synthesis Nnwale ahụ ọ gụnyere ịgbaghara na vitro ejikọtara nyocha nyocha, ma ọ bụ onye nwere mmetụta nke ukwuu dị ndụ ọmụmụ ọgwụ pharmacokinetic ebe trifluoroacetic acid fọdụrụnụ (TFA) ma ọ bụ endotoxins ga-emebi agụgụ nke ndu?

Dị ka Ntuziaka EMA na mmepe na nrụpụta nke Peptides sịntetik (2022), Ndị na-ahụ maka njikwa na-atụ anya traceability n'usoro ọkọnọ zuru oke, njikwa usoro nrụpụta zuru ezu, na nkọwa zuru oke nke ihe mmalite na reagents dị egwu. N'otu aka ahụ, nke Ntuziaka usoro nkwado bioanalytical FDA (2020) na-ekwusi ike na nkwekọ n'ọtụtụ-na-nza na njiri mara nke ọma nke reagents dị oke mkpa maka nleba anya na nrube isi n'usoro iwu..

Iji wuo usoro nyocha nke ndị na-ebubata ihe a pụrụ ịdabere na ya, otu ndị na-emepụta ihe ga-agaferịrị ọnụọgụ ọnụọgụ abụọ na Peptides sịntetik nyochaa nke àgwà, granularity, na ngwa mkpa nke akwụkwọ e bipụtara.

Ihe Nlereanya Ọnụ Ọgụgụ 4-Metric Quantitative

Iji gbanwee data nrụtụ aka qualitative ka ọ bụrụ matriks mkpebi ahaziri ahazi, ịzụ ahịa na R&Ndị otu D nwere ike gbakọọ ihe mejupụtara Akara ntụkwasị obi nke ndị na-ere ahịa (VCS).

Usoro ihe mejupụtara ahụ na-edozi nhụta akwụkwọ, ụzọ ngalaba nghọta, Nhazi ngwa ndu ndu, yana nkwenye data nyocha raw:

VCS = 0.25 × PC + 0.25 × MRI + 0.25 × AAI + 0.25 × CQS

Akụkụ ọ bụla na-anọchi anya akara ahaziri ahazi site na 0 ka 100, enyochara megide kpọmkwem kemịkalụ na akwụkwọ njirisi.

Akara ntụkwasị obi na-ere ere (VCS) VCS = 0.25(PCS) + 0.25(MRI) + 0.25(AAI) + 0.25(CQS)

1. Ntụtu aka nbipụta | 2. Ụzọ siri ike | 3. Ndozi ngwa | 4. Akara Ogo Ogo CoA (PCS) | Index (MRI) | Index (AAI) | (CQS)

• Ọnụ ego JIF | * Ekpughere usoro | * Nyochaa in vitro (50) | * Njikọ HPLC

• Ọsọ mbipụta | * Parameters synthesis | * Na vivo / Anụmanụ (75) | * Njirimara HRMS

• Onwe onye ode akwụkwọ | * Lot / Ọnụọgụ ogbe | * Nhazi / NMR (90) | * Mkpesa / TFA

• Ọkọlọtọ ngalaba-ede akwụkwọ | * Ihe akaebe RP-HPLC/MS nke raw | * GMP / IND pilot (100) | * Nyocha LAL Endotoxin

1. Akara ngụ akwụkwọ (PCS)

Nke Akara ngụ akwụkwọ (PCS) na-atụle ibu ọnụ ọgụgụ na ikike sayensị nke ụlọ ọrụ akwụkwọ na-ehota ndị na-ebubata ya. Ọ na-enye ntaramahụhụ n'onwe ya, ndị mmekọ na-ede akwụkwọ, na akwụkwọ akụkọ anụ ọhịa na-enwe mmetụta dị ala ma na-akwụghachi ụgwọ ọmụmụ nyocha nke ndị ọgbọ nọọrọ onwe ha na akwụkwọ akụkọ biopharma nwere mmetụta dị elu..

PCS = nchikota_{i=1}^{n} ( JIF_i × Agba anabataghị Arọ_i × Ihe Nnwere Onwe_i )

• Ihe Mmetụta Akwụkwọ akụkọ (JIF) Ịdị arọ: Akwụkwọ ndị e bipụtara na akwụkwọ akụkọ ndị ọgbọ nyochara na JIF > 5.0 (eg., Akwụkwọ akụkọ ọgwụ Chemistry, Ọdịdị Chemical Biology, Analytical Chemistry) nata kacha ntọala ịdị arọ.

• Ịdị arọ nke nso nso a: Mbipụta sitere na ikpeazụ 36 ọnwa na-atụ na 1.0; amaokwu ndị tọrọ karịa 5 afọ na-mbelata ka 0.5 iji gosipụta mgbanwe ndị nwere ike ime na ụlọ ọrụ nhazi ma ọ bụ ndị ọrụ.

• Ihe kpatara nnwere onwe: Ntụle ndị otu agụmakwụkwọ nọọrọ onwe ha ma ọ bụ nyocha biopharma dere na-enweta ihe kpatara ya 1.0. Akwụkwọ ndị ndị ọrụ na-ebubata ihe jikọtara ọnụ na-enweta ihe dị mkpa 0.3 imeghari maka nhụsianya nkwado nke ime.

2. Usoro Rigor Index (MRI)

Nke Usoro Rigor Index (MRI) na-akọwapụta ole ndị ode akwụkwọ na-akọwapụta nkọwa nkọwa gbasara njikọ peptide, ime ka ọ dị ọcha, na njirimara nza na ngalaba nnwale ha ebipụtara.

Ụzọ ndị dị elu granularity na-ejikọta nke ọma na nghọta onye na-ere ahịa na ntọgharị ogbe.

Ntugharị igodo: Onye na-ebubata akwụkwọ edeturu ya na-agụnye mgbanwe n'usoro doro anya, ọnọdụ njikọ, ọtụtụ ọnụọgụ, na chromatograms nyocha na-egosipụta ntozu oke n'ichepụta ihe karịa onye nkwuputa ya nwere naanị akara aha..

Ekpughere akụkụ nke usoro ụzọ	Ọnụ ego	Ihe Sayensị Pụtara
Usoro ziri ezi & Okpu ọnụ	15 Isi ihe	Na-ekpughe mgbanwe N-terminal/C-terminal (eg., Ac-, -NH2, PEGylation, fluorophore).
Onye na-ere ahịa & Akpọrọ aha obodo	15 Isi ihe	Na-akwado nkewa njikọ kpọmkwem karịa onye ọzọ erere mpaghara.
Usoro nchịkọta akọwapụtara	20 Isi ihe	Na-akọwapụta SPPS (Fmoc/tBu vs. Boc/Bzl), mmiri mmiri-phase, ma ọ bụ enzymatic/fermentation ụzọ.
Ọkwa Ọcha & Ekwuru usoro HPLC	20 Isi ihe	Ndị na-ekwu maka ịdị ọcha (eg., ≥95%, ≥98%) n'akụkụ kọlụm nyocha na paradient gradient.
Ogbe / Ekpughere ọnụọgụ ọnụọgụ	15 Isi ihe	Na-enye njikọ enwere ike ịchọpụta n'etiti data ndu ebipụtara yana batch mmepụta kpọmkwem.
Ejikọtara Data Analytical Raw	15 Isi ihe	Gụnyere mgbakwunye RP-HPLC chromatograms ma ọ bụ uka spectra (ESI-MS/HRMS).

3. Ndekọ Ndekọ Ngwa (AAI)

Nke Ndekọ Ndekọ Ngwa (AAI) na-enyocha ma akwụkwọ e zoro aka na onye na-ere ahịa dabara na mgbagwoju anya arụ ọrụ nke nyocha gị akọwapụtara ma ọ bụ mmemme mmepe ọgwụ.

Onye na-ebubata ya na 100 nhota maka nkenke, linear antigenic peptides eji na isi ELISA assays nwere ike akara nke ọma mgbe enyochara maka mgbagwoju peptide kemịkalụ..

• Ọkwa 1: Basic In Vitro Assays (Akara: 50/100) - Western blot igbochi, polyclonal antibody ọgbọ, na-ejikọta ELISAs oge niile.

• Ọkwa 2: Omenala Cell mgbagwoju anya & Nleba anya nke ukwuu (Akara: 75/100) - peptides na-abanye cell, arụrụ arụ ọrụ agonism / mgbochi, Nyocha organoid toxicity nke chọrọ ọkwa endotoxin dị ala enwetara.

• Ọkwa 3: Usoro ihe omumu ihe owuwu & Na Vivo Studies (Akara: 90/100) - Cyo-EM, X-ray crystallography, NMR, rodent PK/PD, Nnwale nkwụsi ike na-achọ mgbanwe mgbanwe TFA-to-acetate ziri ezi.

• Ọkwa 4: Tupu ụlọ ọgwụ & Ọmụmụ Usoro Njikere GMP (Akara: 100/100) - IND na-enyere aka ọmụmụ toxicology, mmepe nke ọgwụ mgbochi neoantigen, ọgwụgwọ peptide ndu scaling chọrọ klaasị 100 nhazi ime ụlọ dị ọcha yana faịlụ Master Drug zuru oke (DMF) nkwado.

4. Asambodo ogo ogo nyocha (CQS)

Nke Asambodo ogo ogo nyocha (CQS) na-enyocha akwụkwọ nyocha nke onye na-eweta ngwaahịa. Ngụ akwụkwọ na-akwado arụmọrụ akụkọ ihe mere eme, mana data CoA-ọkwa ogbe na-enyocha iguzosi ike n'ezi ihe mbupu ozugbo.

Dị ka edepụtara n'ime Ụkpụrụ ntụaka PMC maka Peptides sịntetik (2023), njirimara nyocha nke peptides sịntetik ga-akwadorịrị njirimara usoro nke mbụ, monoisotopic molekul arọ, pasent nke ịdị ọcha, yana adịghị ọcha metụtara usoro ihe fọdụrụ.

Iji nweta CQS > 90, akwụkwọ na-ere ahịa ga-enyerịrị: Mmepụta Peptide

1. Chromatogram nke RP-HPLC Raw: Tebụl njikọta zuru oke na-egosipụta pasentị mpaghara kacha elu, oge njide, na mkpebi ndabere—ọ bụghị naanị otu nchịkọta ịdị ọcha ọnụọgụgụ.

2. Mass Spectrometry dị elu (HRMS): ESI-TOF ma ọ bụ MALDI-TOF spectra na-enyocha oke monoisotopic yana gosipụta enweghị usoro nhichapụ., iberibe iberibe, ma ọ bụ mkpochapụ otu nchekwa ezughị ezu (eg., +100 Da Pbf na-akwado).

3. Nyochaa Counterion & Nnwale mgbanwe nnu: Nkwenye doro anya nke ụdị nnu (TFA, acetate, ma ọ bụ hydrochloride). Maka ọmụmụ sel na anụmanụ, A ga-enyocha ma ọ bụ gbanwee TFA fọdụrụnụ ka ọ bụrụ acetate/hydrochloride iji gbochie nsị nke akpụkpọ ahụ..

4. Endotoxin & Nnwale bioburden: Nnwale endotoxin nke LAL (Akuko na EU/mg, kacha mma <0.05 EU / mg maka omenala cell na dị ndụ arụ ọrụ) na nkwenye ịmụ nwa.

Protocol nzọụkwụ site nzọụkwụ: Ntụle akwụkwọ maka ndị na-ere ahịa Reagents

Iji mee ka ụdị ọnụọgụgụ a rụọ ọrụ, ịzụ ahịa na R&Ndị otu D nwere ike soro usoro nyocha akwụkwọ nke usoro 4 ahaziri ahazi n'oge nyocha ntozu ndị na-ebubata ya..

Nzọụkwụ 1: Ọchụchọ Corpus akpaaka (PubMed/PMC eriri dakọtara)

Nzọụkwụ 2: Ụzọ ngalaba mmịpụta & Ntụle (Regex / dabere na iwu) Nzọụkwụ 3: Ndekọ ọnụọgụ ọnụọgụgụ (Kọwaa PCS, MRI, AAI) Nzọụkwụ 4: Analytical CoA Cross-Validation (Dakọtara akwụkwọ na ogbe CoA)

Nzọụkwụ 1: Ọchụchọ Corpus na arụrụ eriri akpaaka

Malite site n'ịjụ nnukwu ọdụ data akwụkwọ (PubMed Central, Ọkà mmụta Google, Europe PMC) iji eriri ọchụchọ Boolean ziri ezi na-ejikọta aha iwu nke onye na-ere ahịa, akara utu aha, na usoro nhazi omenala na peptide nomenclature chemical.

("Supplier Legal Name" OR "Supplier Alias") AND ("custom peptide synthesis" OR "solid-phase peptide synthesis" OR "Fmoc synthesis") AND ("HPLC" OR "mass spectrometry" OR "purification")

Wepụta nsonaazụ ọchụchọ iji kewapụ akụkọ nyocha ndị ọgbọ nyochara mgbe ewepụrụ akwụkwọ nyocha, ngwa patent, na broshọ azụmahịa.

Nzọụkwụ 2: Ịwepụta na ịkọwa akụkụ nke usoro

Nyochaa akụkụ nnwale nke akwụkwọ ewepụtara—kpọmkwem nkebi nke akpọrọ aha "Reagents", "Peptide Synthesis", "Nkọwa nke usoro siri ike", ma ọ bụ "Omenala Cell".

Nyochaa ederede usoro maka akara mkpesa akọwapụtara:

• Ngosipụta okwu nke onye na-eweta ya: Chọọ akpaokwu enweghị mgbagha dịka “emebere ya site na [Aha onye na-ere ere], ịdị ọcha >98% dị ka RP-HPLC siri kpebie".

• Usoro na Ọdịdị doro anya: Lelee ma akwụkwọ akụkọ ahụ ekpughere usoro amino acid zuru oke site na iji koodu mkpụrụedemede 1 ma ọ bụ mkpụrụedemede atọ., gụnyere amino acid na-abụghị nke canonical ma ọ bụ àkwà mmiri disulfide cyclic.

• Mmegharị nnwale: Dị ka Usoro iwu okike SPPS (2007), nkọwa zuru ezu nke nkwado resin, njikọ reagent (eg., Ntụpụ ụkwụ, DIC/Oxyma), ikpochapụ mmanya, na ọnọdụ nchacha nke nyocha dị mkpa maka ụkpụrụ njikọ njikọ peptide nwere ike ịnwapụta.

Nzọụkwụ 3: Ịgbakọ metrik quantitative

Tinye nkọwa mbipụta ewepụtara n'ime matriks nke onye na-ere ihe n'ime gị. Gbakọọ PCS, MRI, na AAI maka onye na-ebubata onye ọ bụla dabere na ihe nnochite anya nke akwụkwọ 10-20 na-adịbeghị anya.

Maka ndụmọdụ: Ọ bụrụ na onye na-ebubata ya na-ekwu nnukwu ahụmahụ biopharma mana gosipụtara akara MRI n'okpuru 40 n'ihi usoro ndị na-edoghị anya nke ngalaba nkwupụta, arịrịọ 3 CoAs nke ndị ahịa na-akpọghị aha iji nyochaa ma nhịahụ nyocha ha dabara na nzọrọ ahịa ha.

Nzọụkwụ 4: Akwụkwọ ntụaka gafefere nwere data CoA dị iche iche

Oge ikpeazụ nke nyocha ahụ na-ejikọta akwụkwọ edemede ozugbo na akwụkwọ nrụpụta ugbu a.

Rịọ CoA dị iche iche maka iwu na nso nso a ma ọ bụ ihe nlele mbupu tupu ndị na-ere ahịa. Tụlee ụzọ nyocha ndị e zoro aka na ya n'akwụkwọ ha ebipụtara na chromatogram raw ndị enyere na CoAs ha.:

• Mee akụkụ kọlụm, mkpanaka usoro gradients (eg., Mmiri/Acetonitrile nwere 0.1% TFA), na nchọta wavelength (214 nm / 220 nm) dakọtara ọkọlọtọ protocol protocol?

• A na-egosi nnukwu ụdịdị dị iche iche nwere nnukwu ego iji chajịa (m/z) ọrụ envelopu maka ịba ụba ion ([M+H]^+, [M+2H]^{2+}, [M+3H]^{3+})?

Matriks Ọmụmụ Okwu: Na-enyocha 3 Profaịlụ ngụ ndị na-ere ere

Iji gosi ka usoro ọnụọgụgụ a si arụ ọrụ n'omume, tụlee ndị na-ebubata peptide atọ nke ndị otu biopharma dị n'etiti na-enyocha omenala 35-mer cyclic peptide nke nwere njikọ intramolecular disulfide abụọ na mpaghara hydrophobic N-terminal nke ukwuu maka mmemme njikarịcha ụzọ oncology..

Ntụle nyocha sitere na Matriks Ọmụmụ Okwu

• Profaịlụ A na-egosi na ọ na-achị mgbe ọ na-ele anya nke ọma na mkpokọta mbipụta (1,200+ akwụkwọ). Agbanyeghị, ya obere MRI (42) na agafeghị oke CQS (65) na-ekpughe na akwụkwọ ya bụ n'ụzọ bụ́ isi dị mfe, ihe katalọgụ dị obere. Mgbe a na-ama aka na mgbagwoju anya cyclic 35-mer peptides, Profaịlụ A na-ebu nnukwu ihe egwu nke mpịachi oxidative ezughị ezu, nchịkọta, ma ọ bụ nnukwu ogbe-na-ogbe mgbanwe mgbanwe.

• Profaịlụ B na-ada n'ofe ọnụọgụ ọnụọgụgụ niile. N'agbanyeghị mgbasa ozi ọnụ ala dị ala, Enweghị usoro ya akụkụ siri ike yana akwụkwọ CoA enyochaghị nke ọma na-egosi njikwa adịghị mma yana mgbanwe nke ogbe-na-ogbe..

• Profaịlụ C (gosiputara site na ikpo okwu siri ike dika nke MOL na-agbanwe ikpo okwu njikọ peptide omenala) na-enweta VCS pụtara ìhè nke 93.25. Agbanyeghị na ọnụ ọgụgụ mbipụta ya dị ala karịa Profaịlụ A, Akwụsị akwụkwọ ya gbadoro anya nke ukwuu na akwụkwọ akụkọ biopharma nwere mmetụta dị elu. Ọzọkwa, Ndekọ ya ebipụtara na-egosipụta nka akwadoro na mpịakọta usoro cyclic siri ike 35-mer, mgbanwe nnu TFA-to-acetate zuru oke, na Klas 100 ultra-sterile nhazi, na-eme ka ọ bụrụ ezigbo onye mmekọ maka njikarịcha ndu ndu biopharmaceutical dị elu.

Na-ejikọta Metrics Citations na Biopharma RFP & Nyochaa usoro ọrụ

Ịzụ ahịa na R&Ndị otu D nwere ike itinye usoro nyocha ọnụọgụgụ a ozugbo n'ime ọkọlọtọ ha na-arịọ arịrịọ maka atụmatụ. (RFP) usoro.

⚠️ Ịdọ aka ná ntị: adaberela na broshuọ ahịa nke onye na-ebubata ya ma ọ bụ oche ahịa dị ka ihe akaebe nke ike nyocha.. Chọrọ ndị na-ere ahịa ka ha nyefee raw, chromatograms RP-HPLC edezighị ya na ụdị HRMS maka ogologo usoro na ụdị mgbanwe ya na ọrụ ebumnuche gị..

Ndepụta nleba anya ịzụ ahịa ga-arụ ọrụ

Tupu ịnye iwu ịzụta ma ọ bụ bịanye aka na nkwekọrịta ọrụ nna ukwu (MSA) maka nhazi peptide omenala, kwado usoro nyocha ndị a:

1. Nyocha akwụkwọ traceability: Chọpụta na ndị na-ere ahịa nwere ike inye opekata mpe 5 mbipụta ndị ọgbọ nyochara n'ime ikpeazụ 36 ọnwa na-egosipụta ihe ịga nke ọma njikọ nke peptides na atụnyere usoro ogologo, hydrophobicities, ma ọ bụ mgbagwoju anya mgbanwe (eg., multi-disulfide bridge, phosphorylated residues, isotope labeling).

2. Ụzọ nghọta Nkebi: Kweepụta nhota ndị ahụ ebipụtara kpọpụta aha n'ụzọ doro anya nọmba batch yana nkọwa njirimara RP-HPLC/MS..

3. Ime ụlọ ọcha & Nyochaa ịmụ nwa: Maka omenala cell, injinia anụ ahụ, ma ọ bụ dị ndụ ngwa, hụ na ndị na-ebubata ya na-arụ ọrụ ụlọ dị ọcha akwadoro. Ọmụmaatụ, mmepụta n'ime a Klas 100 gburugburu ebe obibi ụlọ dị ọcha ultra-sterile na-ewepụ ihe egwu mmetọ microparticle na endotoxin n'oge njikọ na nkwakọ ngwaahịa.

4. Usoro nkwenye nke CoA: Chọrọ nrubeisi CoA tupu ebubu ya nwere tebụl mbanye HPLC raw, monoisotopic mass nkwenye, net peptide ọdịnaya analysis, na mkpesa nnu doro anya (TFA vs. acetate vs. HCl).

5. Scalability na CDMO alignment: Nyochaa usoro njikọ nchoputa mbụ ahụ (milligram ọnụ ọgụgụ) nwere ike ịgafe n'enweghị nsogbu iji hazie ọnụ ọgụgụ elu (gram ka kilogram ọnụ ọgụgụ) na-enweghị ịgbanwe profaịlụ adịghị ọcha ma ọ bụ kemistri dị ọcha. Dị ka e kwuru na Ọnụ ego nke ACS OPR&D Echiche ụlọ ọrụ na peptide sịntetik (2025), mmalite nhọrọ nke scalable njikọ reagents, usoro ihe mgbaze green, na ụzọ nchacha nke siri ike na-egbochi nnabata usoro dị oke ọnụ n'oge mmepe ụlọ ọgwụ na-emecha.

Ajụjụ a na-ajụkarị (FAQ)

Kedu ka ịzụ ahịa ga-esi dị iche n'etiti ezigbo nkọwapụta na aha ndị nkesa ọzọ?

Ndị na-ekesa na-edekarị akwụkwọ ebe a na-akpakọkwa peptides n'okpuru aha ha na-ekwupụtaghị onye nrụpụta nkwekọrịta mbụ.. Ka ịhụta aha ọzọ nkesa akara ọcha, lelee ma ngalaba nnwale ndị ebipụtara na-ezo aka n'usoro njikọ kpọmkwem (eg., ụdị synthesizer akpaaka, resin loading ọnụego, ikpochapụ mmanya). Ndị na-emepụta njikọ mbụ na-enyekarị akwụkwọ teknụzụ miri emi, ebe ndị na-ere ere na-adabere na koodu ngwaahịa ọnụọgụgụ.

Kedu ihe ma ọ bụrụ na onye na-ere ahịa pụrụ iche nwere ngụkọ ole na ole n'ihi mmachi biopharma NDA siri ike?

CDMO nke azụmahịa na ndị na-ebubata biopharma pụrụ iche na-arụkarị ọrụ n'okpuru nkwekọrịta enweghị mkpughe siri ike (NDA) nke na-amachibido ndị ahịa ikpughe aha ndị na-eweta ngwaahịa na akwụkwọ agụmakwụkwọ. N'ọnọdụ ndị dị otú ahụ, nyochaa ndị na-ere ahịa site na iji ụdị akara emezigharịrị: ibu nke Usoro Rigor Index (MRI) na Akara Ogo CoA (CQS) na 40% nke ọ bụla, ma jiri nyocha nleba anya nke ndị ahịa na nyocha saịtị ma ọ bụ mebere ụlọ ọrụ dochie metric ebipụta.

Kedu akara MRI kacha nta na-anabata maka ọmụmụ ọgwụgwọ vivo?

Maka dị ndụ ọmụmụ anụmanụ ma ọ bụ nyocha nchekwa nchekwa IND, ndị otu na-eme ihe kwesịrị ịmanye akara MRI kacha nta nke 80/100 na akara CQS nke 90/100. N'ọkwa a, Ntụtu aka ebipụta na akwụkwọ ogbe ga-akwadorịrị mgbanwe mgbanwe (acetate ma ọ bụ ụdị nnu HCl nwere TFA fọdụrụnụ < 1.0%), ọkwa endotoxin dị n'okpuru 0.05 EU/mg, na RP-HPLC ịdị ọcha ≥ 98%.

Nzọụkwụ ọzọ: Welie ịdọ aka ná ntị ịzụ ahịa Peptide gị

Ịtụgharị akara ukwu akwụkwọ na usoro ntụaka n'ime ọnụọgụ ọnụọgụ na-enye ịzụ ahịa biopharma na R.&D ndú a bụrụkwa uru. Kama ịdabere na nkwuputa ahịa ahịa akwadoghị ma ọ bụ agha ịgbanye ọnụ ahịa kwa milligram, otu nwere ike họrọ ndị mmekọ peptide synthesis dabere na ihe akaebe sayensị, ogbe traceability, na nyocha nyocha pụtara.

Ma ị na-echepụta ọba akwụkwọ peptide cyclic dị mgbagwoju anya, scaling hydrophobic usoro, ma ọ bụ na-akwadebe ihe maka nyocha tupu ụlọ ọgwụ, iso onye ọkachamara njikọ guzosie ike na-emekọ ihe na-eme ka a hụ na mmezu ọrụ enweghị nkebi.

Iji kparịta ihe achọrọ usoro omenala gị, mgbagwoju mgbanwe atụmatụ, ma ọ bụ klas 100 Mkpa mmepụta ihe na-adịghị mma yana ndị chemists peptide nwere ahụmahụ, inyocha na MOL na-agbanwe ikpo okwu njikọ peptide omenala ma rịọ maka ntule nleba anya n'uju taa.